The number of people with susceptibility test result for rifampicin in Türkiye
Türkiye: The number of people with susceptibility test result for rifampicin was 87.71 in 2021. ▬ Flat
Latest (2021)
87.71
Change on year
down 3.1%
World rank
77th
of 146 countries
All-time high
90.53
in 2020
All-time low
86.35
in 2018
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Türkiye, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Türkiye stood at 87.71.
Compared with earlier readings it is down 3.1% on the previous year and up 1.4% over five years.
Türkiye ranks 77th of 146 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Türkiye, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 86.5 | — |
| 2018 | 86.35 | -0.2% |
| 2019 | 88 | +1.9% |
| 2020 | 90.53 | +2.9% |
| 2021 | 87.71 | -3.1% |
Türkiye compared with similar countries
- Türkiye's 87.71 is below the median for upper middle income countries, which is 92.7, 95% of the median. (45 countries reporting)
- Türkiye's 87.71 is below the median for Europe & Central Asia, which is 93.52, 94% of the median. (43 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 86.95 | 86.35 | 88 | 3 |
| 2020s | 89.12 | 87.71 | 90.53 | 2 |
Countries ranked near Türkiye
- 74 Benin 87.94 compare
- 75 United Kingdom of Great Britain and Northern Ireland 87.93 compare
- 76 Cyprus 87.88 compare
- 78 Dominican Republic 87.56 compare
- 79 Switzerland 87.3 compare
- 80 Austria 86.84 compare
More health data for Türkiye
- Un projection of annual infant deaths, annual growth rate -1.72 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5275 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,582 deaths per 1,000 people (2090)
- Number of infants who die before age 1 858 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 1 (2025)
- Population ages 00-04, female, annual growth rate -3.16 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0298 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.94 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Türkiye?
- The number of people with susceptibility test result for rifampicin in Türkiye was 87.71 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Türkiye?
- The highest recorded value was 90.53 in 2020.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Türkiye?
- The lowest recorded value was 86.35 in 2018.
- How does Türkiye rank for the number of people with susceptibility test result for rifampicin?
- Türkiye ranks 77th out of 146 countries with data for 2021.
- Where does this Türkiye data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).